Most participants from the LIBERTY 360° study were free from major adverse events and had improved quality of life at 18 months, according to findings presented at CRT 18. William A. Gray, MD, system ...
The activity needed to induce claudication and the presence of tissue loss is used to categorize patients with PAD according to the Rutherford Classification scheme. Grade 0 patients are asymptomatic ...
HOLLYWOOD, FL—Patients who undergo peripheral vascular intervention (PVI) for symptomatic lower-extremity PAD derive long-term benefits, according to 2.5-year data from the LIBERTY 360 trial presented ...
HOLLYWOOD, FL—The benefit of peripheral vascular intervention (PVI) varies by baseline risk among patients with symptomatic, lower-extremity peripheral artery disease, according to 6-month data from ...
ST. PAUL, Minn.--(BUSINESS WIRE)--Cardiovascular Systems, Inc. (CSI ®) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback